Vasoconstrictor: neurological and cardiovascular adverse effects.
D000328:Adult; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D002648:Child; D004809:Ephedrine / Q000009:adverse effects; D006801:Humans; D010665:Phenylpropanolamine / Q000009:adverse effects; D014662:Vasoconstrictor Agents / Q000009:adverse effects*
D014662:Vasoconstrictor Agents; D010665:Phenylpropanolamine; D004809:Ephedrine